Literature DB >> 6854740

Rubella virus contains one capsid protein and three envelope glycoproteins, E1, E2a, and E2b.

C Oker-Blom, N Kalkkinen, L Kääriäinen, R F Pettersson.   

Abstract

We have analyzed the structure of rubella virus proteins labeled metabolically with [35S]methionine, [3H]mannose, and [3H]glucosamine or externally with [3H]borohydride after galactose oxidase treatment. Four structural proteins, with MrS of about 58,000 (E1), 47,000 (E2a), 42,000 (E2b), and 33,000 (C), were resolved on sodium dodecyl sulfate-polyacrylamide gels. Tryptic peptide maps obtained from [35S]methionine-labeled proteins indicated that E1 and C were unrelated to each other and to E2a and E2b, whereas the latter two gave similar, if not identical, maps. E1, E2a, and E2b were associated with the envelope and were located externally on the virus particle, whereas the C protein was associated with the RNA in the nucleocapsid. Solubilization of the virus with Triton X-100, followed by removal of the nucleocapsid and the detergent, resulted in the formation of soluble envelope protein complexes (rosettes) containing E1, E2a, and E2b. Although external labeling with [3H]borohydride and metabolic labeling with [3H]glucosamine suggested that all three proteins were glycosylated, only E1 and E2b were efficiently labeled with [3H]mannose. It is thus possible that the difference in migration between E2a and E2b is due to differences in glycosylation. Analysis by immunoprecipitation and sodium dodecyl sulfate-gel electrophoresis of intracellular [35S]methionine-labeled structural proteins synthesized in the presence and absence of tunicamycin supported the conclusion that E1 and E2 are glycoproteins. Unglycosylated E1 and E2 had an Mr of about 53,000 and 30,000, respectively.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6854740      PMCID: PMC256571     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  Structural components of Uukuniemi virus, a noncubical tick-borne arbovirus.

Authors:  R Pettersson; L Kääriäinen; C H von Bonsdorff; N Oker-Blom
Journal:  Virology       Date:  1971-12       Impact factor: 3.616

2.  External labeling of cell surface galactose and galactosamine in glycolipid and glycoprotein of human erythrocytes.

Authors:  C G Gahmberg; S I Hakomori
Journal:  J Biol Chem       Date:  1973-06-25       Impact factor: 5.157

3.  The ribonucleic acids of Uukuniemi virus, a noncubical tick-borne arbovirus.

Authors:  R Pettersson; L Kääriäinen
Journal:  Virology       Date:  1973-12       Impact factor: 3.616

4.  A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels.

Authors:  W M Bonner; R A Laskey
Journal:  Eur J Biochem       Date:  1974-07-01

5.  The structural proteins of rubella virus.

Authors:  H Liebhaber; P A Gross
Journal:  Virology       Date:  1972-03       Impact factor: 3.616

6.  Structural proteins and subunits of rubella virus.

Authors:  A Vaheri; T Hovi
Journal:  J Virol       Date:  1972-01       Impact factor: 5.103

7.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

8.  Morphology of the isolated hemagglutinin and neuraminidase subunits of influenza virus.

Authors:  W G Laver; R C Valentine
Journal:  Virology       Date:  1969-05       Impact factor: 3.616

9.  The release of intact oligosaccharides from specific glycoproteins by endo-beta-N-acetylglucosaminidase H.

Authors:  A L Tarentino; T H Plummer; F Maley
Journal:  J Biol Chem       Date:  1974-02-10       Impact factor: 5.157

10.  Purification of rubella virus particles.

Authors:  A Vaheri; C H von Bonsdorff; T Vesikari; T Hovi; P Väänänen
Journal:  J Gen Virol       Date:  1969-07       Impact factor: 3.891

View more
  68 in total

1.  Intracellular distribution of rubella virus nonstructural protein P150.

Authors:  P Kujala; T Ahola; N Ehsani; P Auvinen; H Vihinen; L Kääriäinen
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

2.  Role of rubella virus glycoprotein domains in assembly of virus-like particles.

Authors:  M Garbutt; L M Law; H Chan; T C Hobman
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

3.  Evaluation of antibodies against a rubella virus neutralizing domain for determination of immune status.

Authors:  P Cordoba; A Lanoel; S Grutadauria; M Zapata
Journal:  Clin Diagn Lab Immunol       Date:  2000-11

Review 4.  Rubella virus replication and links to teratogenicity.

Authors:  J Y Lee; D S Bowden
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

5.  Cellular and humoral immune responses to rubella virus structural proteins E1, E2, and C.

Authors:  H H Chaye; C A Mauracher; A J Tingle; S Gillam
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

6.  The E2 signal sequence of rubella virus remains part of the capsid protein and confers membrane association in vitro.

Authors:  M Suomalainen; H Garoff; M D Baron
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

7.  Role of N-linked oligosaccharides in processing and intracellular transport of E2 glycoprotein of rubella virus.

Authors:  Z Qiu; T C Hobman; H L McDonald; N O Seto; S Gillam
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

8.  Structure of rubella E1 glycoprotein epitopes established by multiple peptide synthesis.

Authors:  L Lozzi; M Rustici; M Corti; M G Cusi; P E Valensin; L Bracci; A Santucci; P Soldani; A Spreafico; P Neri
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

9.  Construction of rubella virus genome-length cDNA clones and synthesis of infectious RNA transcripts.

Authors:  C Y Wang; G Dominguez; T K Frey
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

10.  Expression and characterization of virus-like particles containing rubella virus structural proteins.

Authors:  Z Qiu; D Ou; T C Hobman; S Gillam
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.